Nifty
Sensex
:
:
11896.45
40558.49
-41.20 (-0.35%)
-148.82 (-0.37%)

Pharmaceuticals & Drugs - Domestic

Rating :
81/99

BSE: 506820 | NSE: ASTRAZEN

4229.50
22-Oct-2020
  • Open
  • High
  • Low
  • Previous Close
  •  4200.00
  •  4255.00
  •  4126.30
  •  4294.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  34150
  •  1437.92
  •  4970.00
  •  1885.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,578.25
  • 154.88
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,325.73
  • 0.02%
  • 28.15

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.63%
  • 18.35%
  • FII
  • DII
  • Others
  • 1.98%
  • 2.24%
  • 0.80%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 8.09
  • 13.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 49.03
  • 21.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 68.86
  • 40.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 85.81
  • 115.13
  • 113.33

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.27
  • 22.27
  • 22.27

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 44.31
  • 60.66
  • 58.05

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma planning to launch Acalabrutinib capsules ‘Calquence’
    16th Oct 2020, 11:28 AM

    Acalabrutinib100mg capsules Calquence is indicated for the treatment of patients with MCL who have received at least one prior therapy

    Read More
  • Astrazeneca Pharma I - Quarterly Results
    10th Aug 2020, 14:12 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.